---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-21-145529"
form_type: "8-K"
ticker: "PTPI"
cik: "0001815903"
company_name: "Petros Pharmaceuticals, Inc."
filed_at: "2021-12-01T23:59:59+00:00"
generated_at: "2026-06-28T04:33:54.588583+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Petros Pharmaceuticals raises $10M in registered direct offering and private placement

## Summary
- Gross proceeds of $10M from sale of 3,333,333 shares at $3.00/share; net proceeds ~$9.3M.
- Issues warrants to purchase 2,500,000 shares at $3.50/share, exercisable for 5 years.
- Largest shareholder among existing investors; Katalyst Securities acted as financial advisor.
- Proceeds to be used for men's health platform expansion and general corporate purposes.
- Closing expected on or about December 2, 2021, subject to customary conditions.

## SEC filing metadata
- accession: 0001104659-21-145529
- form_type: 8-K
- ticker: PTPI
- cik: 0001815903
- company_name: Petros Pharmaceuticals, Inc.
- filed_at: 2021-12-01T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1815903/000110465921145529/0001104659-21-145529-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1815903/000110465921145529/tm2134293d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-21-145529
- JSON: https://secwatch.observer/filing/0001104659-21-145529.json
- Plain text: https://secwatch.observer/filing/0001104659-21-145529.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.